A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Baricitinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Baricitinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Baricitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Baricitinib Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Baricitinib D4 (azetidine-2,2,4,4-d4) Stable Isotopes CS-O-39795 1564241-99-1 Enquire
Baricitinib-D4 (azetidine-2,2-d2)(Ethyl-1,1-d2) Stable Isotopes CS-O-36661 1564241-55-9 Enquire
Baricitinib-d5 Stable Isotopes CS-EO-01169 1564241-79-7 In Stock


API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Baricitinib API Standards CS-T-48553 1187594-09-7 In Stock
Baricitinib phosphate API Standards CS-ZH-11457 1187595-84-1 Enquire


Impurities

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Acetamide Baricitinib Impurity Impurities CS-EO-01936 2271228-51-2 In Stock
Barcitinib Lactone Impurity Impurities CS-O-38670 2910813-43-1 Enquire
Baricitinib 3-Hydroxy Impurity Impurities CS-O-54068 Not Available Enquire
Baricitinib Acetic Acid Impurity Impurities CS-EO-01083 2271228-52-3 Enquire
Baricitinib Acid impurity Impurities CS-ED-02440 Not Available Enquire
Baricitinib Impurity 2 Impurities CS-O-34971 Not Available Enquire
Baricitinib Impurity 20 Impurities CS-EO-02241 Not Available Enquire
Baricitinib Impurity 21 Impurities CS-EO-02242 Not Available Enquire
Baricitinib Impurity 28 Impurities CS-O-40695 1187595-90-9 Enquire
Baricitinib Impurity 3 Impurities CS-P-08519 1187595-89-6 Enquire
Baricitinib Impurity 76 Impurities CS-O-59561 Not Available Enquire
Baricitinib Impurity 77 Impurities CS-O-59562 Not Available Enquire
Baricitinib impurity C Impurities CS-O-37771 2055723-13-0 In Stock
Baricitinib Impurity I Impurities CS-O-41919 Not Available Enquire
Baricitinib Methyl Ester Impurity Impurities CS-O-38524 2402776-80-9 Enquire
BRY-II Impurities CS-T-94277 1627504-43-1 Enquire
N-Desethylsulfonyl N-Propylsulfonyl Baricitinib Impurities CS-O-38525 1187594-34-8 Enquire
Pyrrolopyrimidine Baricitinib Impurities CS-O-38526 2910813-45-3 Enquire


Intermediates

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile Intermediates CS-EM-00672 1187595-85-2 In Stock
Baricitinib Boronic acid intermediate Intermediates CS-O-46514 1919837-50-5 In Stock
Tert-butyl 3-(cyanomethylene)azetidine-1-carboxylate Intermediates CS-EM-00727 1153949-11-1 In Stock